To examine the PSMA-specific accumulation of our ligands in human prostate cancer, tissue samples were incubated with 111In-labeled N064 and N140, the best performing DOTAGA and DOTA compounds, respectively (Figure 2, Figure 6). Here, FOLH1 is linked to prostate carcinoma.